Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Open Access
- 20 June 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 55 (7), 905-914
- https://doi.org/10.1093/cid/cis580
Abstract
Background. Bacteremia is a frequent complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). It is unclear whether changes in the intestinal microbiota during allo-HSCT contribute to the development of bacteremia. We examined the microbiota of patients undergoing allo-HSCT, and correlated microbial shifts with the risk of bacteremia. Methods. Fecal specimens were collected longitudinally from 94 patients undergoing allo-HSCT, from before transplant until 35 days after transplant. The intestinal microbiota was characterized by 454 pyrosequencing of the V1-V3 region of bacterial 16S ribosomal RNA genes. Microbial diversity was estimated by grouping sequences into operational taxonomic units and calculating the Shannon diversity index. Phylogenetic classification was obtained using the Ribosomal Database Project classifier. Associations of the microbiota with clinical predictors and outcomes were evaluated. Results. During allo-HSCT, patients developed reduced diversity, with marked shifts in bacterial populations inhabiting the gut. Intestinal domination, defined as occupation of at least 30% of the microbiota by a single predominating bacterial taxon, occurred frequently. Commonly encountered dominating organisms included Enterococcus, Streptococcus, and various Proteobacteria. Enterococcal domination was increased 3-fold by metronidazole administration, whereas domination by Proteobacteria was reduced 10-fold by fluoroquinolone administration. As a predictor of outcomes, enterococcal domination increased the risk of Vancomycin-resistant Enterococcus bacteremia 9-fold, and proteobacterial domination increased the risk of gram-negative rod bacteremia 5-fold. Conclusions. During allo-HSCT, the diversity and stability of the intestinal flora are disrupted, resulting in domination by bacteria associated with subsequent bacteremia. Assessment of fecal microbiota identifies patients at highest risk for bloodstream infection during allo-HCST.Keywords
This publication has 41 references indexed in Scilit:
- Short pyrosequencing reads suffice for accurate microbial community analysisNucleic Acids Research, 2007
- Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplantBone Marrow Transplantation, 2005
- The Role of the Intestinal Tract as a Reservoir and Source for Transmission of Nosocomial PathogensClinical Infectious Diseases, 2004
- Antibiotic-Associated Diarrhea Accompanied by Large-Scale Alterations in the Composition of the Fecal MicrobiotaJournal of Clinical Microbiology, 2004
- Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: A matched control studyTransplantation and Cellular Therapy, 2002
- A Solution to the Problem of Monotone Likelihood in Cox RegressionBiometrics, 2001
- Effect of Antibiotic Therapy on the Density of Vancomycin-Resistant Enterococci in the Stool of Colonized PatientsNew England Journal of Medicine, 2000
- The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantationBlood, 2000
- The role of microflora in development of graft-versus-host disease.1976
- Colonization resistance of the digestive tract in conventional and antibiotic-treated miceEpidemiology and Infection, 1971